Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-06

FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the original application (ANDA) for Dapagliflozin and Metformin Hydrochloride from Aurobindo Pharma Limited, a generic combination therapy for type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin and metformin hydrochloride (dapagliflozin and metformin hydrochloride)

Snippet

ORIG AP for DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)